QIAGEN N.V.
Here’s whether QIAGEN N.V. (QGEN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.42% over 10 days); RSI 60 — healthy momentum range; 3-month momentum positive (+25.3%); rising volume confirms the move (1.27x 30d avg). Concerns: weak 1-year return of -10.3%. Currently 23.8% off its 52-week high. Score: +6/7.
QGEN is in a confirmed uptrend, trading above both its 50-day ($40.69) and 200-day ($42.76) moving averages. An RSI of 59.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -10.3% compares to +20.5% for SPY (trailed the market by 30.8%). The current 23.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.